Home/ Stocks/ TKNO

Alpha Teknova, Inc. Common Stock

TKNO XNAS

$6.46 -0.07 (-1.07%) ▼ 15-min delayed

Open

$6.53

High

$6.64

Low

$6.23

Volume

151.4K

Market Cap

$350.10M

About Alpha Teknova, Inc. Common Stock

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 158 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$11.08M	$-4,555,000	$-0.08
FY 2025	$40.52M	$-17,259,000	$-0.32
Q3 2025	$10.45M	$-4,286,000	$-0.08
Q2 2025	$10.29M	$-3,570,000	$-0.07

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for TKNO yet. Check out our latest market news or earnings calendar.

Get TKNO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Alpha Teknova, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.